133 related articles for article (PubMed ID: 2462815)
1. Serum antibodies to peripheral nerve antigens in Guillain-Barré syndrome.
Negishi T; Yamashita T; Nomura K; Hosokawa T; Ohno R; Hamaguchi K; Uyemura K
Ann N Y Acad Sci; 1988; 540():376-7. PubMed ID: 2462815
[No Abstract] [Full Text] [Related]
2. Complement-fixing antiperipheral myelin antibodies and C9 neoantigen in serum of patients with Guillain-Barré syndrome: quantitation, kinetics, and clinical correlation.
Koski CL
Ann N Y Acad Sci; 1987; 505():319-25. PubMed ID: 3479928
[No Abstract] [Full Text] [Related]
3. Macrophage procoagulant activity as a measure of cell-mediated immunity to P2 protein of peripheral nerves in the Guillain-Barré syndrome.
Geczy C; Raper R; Roberts IM; Meyer P; Bernard CC
J Neuroimmunol; 1985 Aug; 9(3-4):179-91. PubMed ID: 2410449
[TBL] [Abstract][Full Text] [Related]
4. Antibody responses to P0 and P2 myelin proteins in Guillain-Barré syndrome and chronic idiopathic demyelinating polyradiculoneuropathy.
Khalili-Shirazi A; Atkinson P; Gregson N; Hughes RA
J Neuroimmunol; 1993 Jul; 46(1-2):245-51. PubMed ID: 7689591
[TBL] [Abstract][Full Text] [Related]
5. Peripheral nerve P2 basic protein and the Guillain-Barré syndrome. In vitro demonstration of P2-specific antibody-secreting cells.
Luijten JA; De Jong WA; Demel RA; Heijnen CJ; Ballieux RE
J Neurol Sci; 1984; 66(2-3):209-16. PubMed ID: 6085109
[TBL] [Abstract][Full Text] [Related]
6. Characterization of complement-fixing antibodies to peripheral nerve myelin in Guillain-Barré syndrome.
Koski CL
Ann Neurol; 1990; 27 Suppl():S44-7. PubMed ID: 2194426
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of antibodies against peripheral nerve tissue in inflammatory polyneuropathy.
van Doorn PA; Brand A; Vermeulen M
Neurology; 1987 Nov; 37(11):1798-802. PubMed ID: 3670618
[TBL] [Abstract][Full Text] [Related]
8. HLA and anti-GQ1b IgG antibody in Miller Fisher syndrome and Guillain-Barré syndrome.
Chiba A; Kusunoki S; Kuwata S; Juji T; Shibata Y; Kanazawa I
J Neuroimmunol; 1995 Aug; 61(1):85-8. PubMed ID: 7560017
[TBL] [Abstract][Full Text] [Related]
9. Specificity of antiglycolipid antibodies.
Baumann N
Clin Rev Allergy Immunol; 2000 Aug; 19(1):31-40. PubMed ID: 11064824
[No Abstract] [Full Text] [Related]
10. Association with autoimmune diseases and cellular immune response to the neuritogenic protein in Guillain-Barré syndrome.
Abramsky O; Korn-Lubetzky I; Teitelbaum D
Trans Am Neurol Assoc; 1980; 105():350-4. PubMed ID: 7348980
[No Abstract] [Full Text] [Related]
11. Serum antibodies to peripheral nerve tissue in acute Guillain-Barré syndrome in relation to outcome of plasma exchange.
Osterman PO; Vedeler CA; Ryberg B; Fagius J; Nyland H
J Neurol; 1988 May; 235(5):285-9. PubMed ID: 3385444
[TBL] [Abstract][Full Text] [Related]
12. Acute and chronic demyelinating inflammatory polyradiculoneuropathy. Association with autoimmune diseases and lymphocyte response to human neuritogenic protein.
Korn-Lubetzki I; Abramsky O
Arch Neurol; 1986 Jun; 43(6):604-8. PubMed ID: 2424413
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal antibodies to P2 basic protein and their use in the investigation of some aspects of the Guillain-Barré syndrome.
Luijten JA; Reijneveld-de Jong SD; Teerlink T; Camps VT; Osterhaus AD; UytdeHaag AG
J Neurol Sci; 1988 Sep; 86(2-3):265-76. PubMed ID: 2464668
[TBL] [Abstract][Full Text] [Related]
14. Clinical relevance of the determination of anti-GQ1b antibodies in Miller Fisher and Guillain-Barré syndromes.
Goffette S; Jeanjean A; Pierret F; Peeters A; Sindic CJ
Acta Neurol Belg; 1998 Dec; 98(4):322-6. PubMed ID: 9922819
[TBL] [Abstract][Full Text] [Related]
15. Antibodies to gangliosides and myelin proteins in Guillain-Barré syndrome.
Quarles RH; Ilyas AA; Willison HJ
Ann Neurol; 1990; 27 Suppl():S48-52. PubMed ID: 2194427
[TBL] [Abstract][Full Text] [Related]
16. Antibody binding to PNS myelin proteins in acute Guillain-Barré syndrome.
Shuman S; Zweiman B; Lisak R; Kahn S; Rostami A; Sumner A
Pathol Immunopathol Res; 1988; 7(3):162-8. PubMed ID: 3194353
[No Abstract] [Full Text] [Related]
17. The clinical effect and the effect on serum IgG antibodies to peripheral nerve tissue of plasma exchange in patients wit Guillain-Barré syndrome.
Vedeler CA; Nyland H; Fagius J; Osterman PO; Matre R; Aarli JA; Janzen RW; Jacobsen H; Skre H
J Neurol; 1982; 228(1):59-64. PubMed ID: 6184459
[TBL] [Abstract][Full Text] [Related]
18. Guillain-Barré syndrome: demonstration of antibodies to peripheral nerve tissue.
Nyland H; Aarli JA
Acta Neurol Scand; 1978 Jul; 58(1):35-43. PubMed ID: 707033
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal IgM autoantibody reactivity in M-IgM peripheral neuropathy.
Caudie C
Clin Rev Allergy Immunol; 2000 Aug; 19(1):7-18. PubMed ID: 11064822
[No Abstract] [Full Text] [Related]
20. Immunologic studies of rabies vaccination-induced Guillain-Barré syndrome.
Hemachudha T; Griffin DE; Chen WW; Johnson RT
Neurology; 1988 Mar; 38(3):375-8. PubMed ID: 2450302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
